EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms

Yoshitaka Sato iD, Yusuke Okuno, Takayuki Murata, Hiroshi Kimura

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70798 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Yoshitaka Sato und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Killer Cells, Natural, Lymphoma, Extranodal NK-T-Cell. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Science (JSPS) KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein–Barr virus (EBV)‐associated T‐ and natural killer (NK)‐cell neoplasms encompass a heterogeneous spectrum, ranging from persistent lymphoproliferative disorders (e.g., severe mosquito bite allergy, systemic chronic active EBV disease) to highly aggressive malignancies (e.g., extranodal NK/T‐cell lymphoma [ENKTL], aggressive NK‐cell leukemia). Genomic and epigenetic studies have revealed shared host genetic alterations—most notably in JAK–STAT signaling, epigenetic regulators, TP53, and DDX3X—supporting a pathogenic and clinicobiological continuum across these disorders. Defective EBV further reshapes viral gene expression programs and contributes to oncogenesis. l ‐asparaginase‐based chemoradiotherapy has improved outcomes in early‐stage ENKTL; however, effective treatments for advanced‐stage disease and other EBV‐associated T/NK‐cell neoplasms remain limited. Emerging molecular subclassifications and large‐scale prospective cohorts can help clarify disease heterogeneity and accelerate the development of precision therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsHerpesvirus 4, HumanKiller Cells, NaturalLymphoma, Extranodal NK-T-CellHumans

Stichwörter der Autor:innen

ANKLCAEBVEBVENKTLHV‐LPDT/NK neoplasms

Autor:innen und Institutionen

  • Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Virology, Fujita Health University School of Medicine, Toyoake, Japan.

ORCID-Profile: Yoshitaka Sato

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • Japan Society for the Promotion of Science (JSPS) KAKENHI

Zitieren

APA

Sato, Y., Okuno, Y., Murata, T., & Kimura, H. (2026). Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms. Journal of Medical Virology. https://doi.org/10.1002/jmv.70798

Vancouver

Sato Y, Okuno Y, Murata T, Kimura H. Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms. Journal of Medical Virology. 2026. doi:10.1002/jmv.70798

BibTeX
@article{Sato2026,
  author = {Sato, Yoshitaka and Okuno, Yusuke and Murata, Takayuki and Kimura, Hiroshi},
  title = {Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70798}
}
Kostenlos starten →